|
Volumn 33, Issue 6, 2015, Pages 589-590
|
Accelerating innovation in rapid diagnostics and targeted antibacterials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
BACTERIAL INFECTION;
DIAGNOSTIC TEST;
DRUG EFFICACY;
DRUG LEGISLATION;
DRUG MANUFACTURE;
DRUG RESEARCH;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
ENTEROBACTERIACEAE;
FATTY ACID SYNTHESIS;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
HEALTH CARE POLICY;
HEALTH CARE QUALITY;
HUMAN;
LETTER;
NONHUMAN;
OFF LABEL DRUG USE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
RISK BENEFIT ANALYSIS;
STAPHYLOCOCCUS AUREUS;
TRANSLATIONAL RESEARCH;
BACTERIAL INFECTIONS;
DRUG DEVELOPMENT;
LEGISLATION AND JURISPRUDENCE;
UNITED STATES;
BACTERIAL INFECTIONS;
DRUG DISCOVERY;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
UNITED STATES GOVERNMENT AGENCIES;
|
EID: 84930933863
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.3251 Document Type: Letter |
Times cited : (7)
|
References (12)
|